GARLAND, Texas, May 29, 2024 /PRNewswire/ — BearCom, a premier North American integrator of voice, security & data solutions, today announced the appointments of Tom Echols as Vice President of Security Solutions and Mike Pietrunti as Vice President of Mergers & Acquisitions. These…
Month: May 2024
Corporater named a Market Leader in Integrated Risk Management (IRM)
STAVANGER, Norway, May 29, 2024 /PRNewswire/ — Corporater, a global leader in software solutions for Integrated Governance, Performance, Risk, and Compliance (GPRC) Management, is proud to announce the recognition as a Market Leader in Wheelhouse Advisors’ 2024 Integrated Risk Management…
SpliSense Receives FDA Fast Track Designation for SPL84 for the Treatment of Cystic Fibrosis
JERUSALEM, May 29, 2024 /PRNewswire/ — SpliSense, a clinical-stage biotechnology company focused on the development of transformative RNA-based therapies for pulmonary diseases including cystic fibrosis (CF), muco-obstructive diseases like COPD, asthma and NCFB and idiopathic pulmonary…
CME Group Inc. Announces Second-Quarter 2024 Earnings Release, Conference Call
CHICAGO, May 29, 2024 /PRNewswire/ — CME Group Inc. will announce earnings for the second quarter of 2024 before the markets open on Wednesday, July 24, 2024. Written highlights for the quarter will be posted on the company’s website at 6:00 a.m. Central Time, the same time it provides…
McCormack Plastic Surgery Accelerates Growth in Collaboration with Cosmetic Physician Partners
DALLAS, May 29, 2024 /PRNewswire/ — McCormack Plastic Surgery is excited to announce its partnership with Cosmetic Physician Partners (CPP), a distinguished network of 38 leading medical aesthetics clinics throughout the United States. McCormack Plastic Surgery, contributes its respected…
HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max
SHANGHAI and REDWOOD CITY, Calif. , May 29, 2024 /PRNewswire/ — HuidaGene Therapeutics (“HuidaGene”), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation (“Synthego”), a leading provider of innovative CRISPR…
Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day
Reports new positive interim data from the ongoing Phase 1 study of BHV-1300, Biohaven’s lead investigational drug from its Molecular Degrader of Extracellular Proteins (MoDE™) platform BHV-1300 demonstrates dose-dependent and rapid IgG reductions within hours of administration No SAEs,…
Corporater named a Market Leader in Integrated Risk Management (IRM)
STAVANGER, Norway, May 29, 2024 /PRNewswire/ — Corporater, a global leader in software solutions for Integrated Governance, Performance, Risk, and Compliance (GPRC) Management, is proud to announce the recognition as a Market Leader in Wheelhouse Advisors’ 2024 Integrated Risk Management…
Precision for Medicine Acquires Algorics, Enhancing Clinical Technologies and APAC Presence
Acquisition adds two proprietary clinical technologies to its portfolio and enhances Precision’s global capabilities in clinical data management, biostatistics and programming BETHESDA, Md., May 29, 2024 /PRNewswire/ — Precision for Medicine, a global leader in biomarker-driven clinical…
Showcasing Japan’s food products and culinary culture at an event dedicated to Franco-Japanese tourism
PARIS, May 29, 2024 /PRNewswire/ — On Thursday, May 2, 2024, as part of the council meeting of the OECD (Organisation for Economic Co-operation and Development) in Paris, an event dedicated to Franco-Japanese tourism was organized by the Japan Tourism Agency (JTA) and the Japan National…
